BPMC - Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q3 2020 Results - Earnings Call Transcript

Blueprint Medicines Corporation (BPMC) Q3 2020 Earnings Conference Call Oct 29, 2020 8:30 AM ET Company Participants Kristin Hodous - Senior Manager, IR Jeff Albers - CEO Christy Rossi - COO Mike Landsittel - CFO Conference Call Participants Marc Frahm - Cowen and Company Reni Benjamin - JMP Securities Andrew Berens - SVB Leerink Peter Lawson - Barclays David Lebowitz - Morgan Stanley Nicole Gabreski - Piper Sandler Dane Leone - Raymond James Arlinda Lee - Canaccord Genuity Inc Michael Schmidt - Guggenheim Securities David Nierengarten - Wedbush PacGrow Life Sciences Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to the Blueprint Medicines Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. I’d now like to hand the

For further details see:

Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q3 2020 Results - Earnings Call Transcript